Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 98301-98350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06382493
Tegoprazan-containing Sequential for H. Pylori
NARecruiting
400 participants
Started: Feb 1, 2021 · Completed: Dec 12, 2024
1 condition1 sponsor1 location
NCT04704037
Mobilizing Early Management of Mental Health Complications After Mild Traumatic Brain Injury
NAActive, not recruiting
537 participants
Started: Feb 1, 2021 · Completed: Oct 30, 2025
1 condition2 sponsors9 locations
NCT04746417
Assessment of Skeletal Maturity Using Proximal Femoral Epiphysis in Patients With Scoliosis
N/ARecruiting
70 participants
Started: Feb 1, 2021 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT04755309
Efficacy of an Early Rhythmic Intervention in Infancy
NAEnrolling by invitation
125 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT04638530
Breaking Bad News to Family Members in a Pandemic
NARecruiting
16 participants
Started: Feb 1, 2021 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT04452825
A New Psychotherapy Intervention for Older Cancer Patients
NARecruiting
459 participants
Started: Feb 1, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04978571
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
NARecruiting
125 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT04640259
Epidemiology of Young Lung Cancer - Survey
N/AActive, not recruiting
250 participants
Started: Feb 1, 2021 · Completed: Mar 31, 2026
1 condition3 sponsors2 locations
NCT04997252
An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer
NARecruiting
50 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03651349
To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers
PHASE1Active, not recruiting
56 participants
Started: Feb 1, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04709302
Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa
N/AEnrolling by invitation
342 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2025
3 conditions6 sponsors3 locations
NCT04230616
Efficacy and Safety of NAVIO
NARecruiting
180 participants
Started: Feb 1, 2021 · Completed: Feb 28, 2030
1 condition1 sponsor1 location
NCT04691297
Digitally Enhanced Smoking Cessation for High Risk Smokers
NAActive, not recruiting
153 participants
Started: Feb 1, 2021 · Completed: Dec 1, 2025
5 conditions2 sponsors2 locations
NCT05020158
The Family Talk Intervention When a Parent With Dependent Children or a Child is Severely Ill
NARecruiting
150 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04700878
A Randomized Controlled Evaluation of a Compassion-course for Healthcare Professionals
NARecruiting
548 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2027
4 conditions5 sponsors1 location
NCT04738708
Telegenetics or In-Person Genetic Counselling
N/ARecruiting
150 participants
Started: Feb 1, 2021 · Completed: Oct 16, 2025
1 condition1 sponsor1 location
NCT04713722
Early Life Stress and Depression: Molecular and Functional Imaging
N/ARecruiting
160 participants
Started: Feb 1, 2021 · Completed: Apr 1, 2025
2 conditions1 sponsor1 location
NCT04113044
Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®
N/ARecruiting
3,500 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2026
5 conditions1 sponsor15 locations
NCT05488704
The Effect of Nonstress Test Device Noise Level on Stress Parameters in Primiparous Pregnant Women
N/AActive, not recruiting
44 participants
Started: Feb 1, 2021 · Completed: Jul 28, 2028
5 conditions1 sponsor1 location
NCT04746209
Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT
PHASE2Recruiting
25 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2029
3 conditions3 sponsors1 location
NCT05339204
The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission
NARecruiting
75 participants
Started: Feb 1, 2021 · Completed: Feb 1, 2026
1 condition10 sponsors1 location
NCT04469569
Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors
NAActive, not recruiting
5,196 participants
Started: Feb 1, 2021 · Completed: Jan 31, 2026
1 condition2 sponsors6 locations
NCT04736823
A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC
PHASE2Recruiting
296 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04675918
Pediatric In-Hospital Cardiac Arrest International Registry (PACHIN)
N/ARecruiting
500 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT04268706
Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)
PHASE2Active, not recruiting
97 participants
Started: Feb 1, 2021 · Completed: Mar 31, 2037
4 conditions1 sponsor5 locations
NCT04315727
Identification of the Genetic Causes of Rare Diseases With Negative Exome Findings
NARecruiting
100 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor2 locations
NCT04869631
Screening for Amyloidosis Before Aortic Valve Elective Replacement
N/AActive, not recruiting
1,000 participants
Started: Feb 1, 2021 · Completed: Mar 31, 2028
2 conditions3 sponsors1 location
NCT04826705
A Study of Endovascular Treatment of Femoropopliteal Arterial Occlusive Lesion With Drug-Coated Balloon
N/AActive, not recruiting
2,000 participants
Started: Feb 1, 2021 · Completed: Feb 1, 2027
3 conditions8 sponsors9 locations
NCT04579900
Dissecting Host-microbiome Modifiers of Type 2 Diabetes Risk
NARecruiting
40 participants
Started: Feb 1, 2021 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05110963
Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments
NAActive, not recruiting
3,771 participants
Started: Feb 1, 2021 · Completed: Nov 1, 2026
1 condition2 sponsors2 locations
NCT04805658
Natural History Study of Retinitis Pigmentosa Type 11
N/AActive, not recruiting
30 participants
Started: Feb 1, 2021 · Completed: Apr 1, 2028
2 conditions1 sponsor1 location
NCT04561739
Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions
NAActive, not recruiting
2,272 participants
Started: Feb 1, 2021 · Completed: May 5, 2027
2 conditions1 sponsor1 location
NCT04488289
The Föllinge Hypertension and Lifestyle Study
NAActive, not recruiting
117 participants
Started: Feb 1, 2021 · Completed: Dec 30, 2023
2 conditions1 sponsor1 location
NCT04520737
Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases
NARecruiting
84 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT04724603
Phage Safety Retrospective Cohort Study
N/ARecruiting
25 participants
Started: Feb 1, 2021 · Completed: Sep 1, 2026
2 conditions1 sponsor1 location
NCT04467983
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
PHASE4Active, not recruiting
70 participants
Started: Feb 1, 2021 · Completed: Dec 1, 2026
1 condition3 sponsors1 location
NCT04651452
Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors
NAActive, not recruiting
250 participants
Started: Feb 1, 2021 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT04229043
Gastric Emptying of Water and Sports Drink in Labor
NARecruiting
108 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06958341
Neuroimmunology Registry and Biobank
N/ARecruiting
300 participants
Started: Feb 1, 2021 · Completed: Jul 1, 2031
8 conditions2 sponsors2 locations
NCT04796766
Human Electrophysiological Model to Quantify the CGRP-related Axon Reflex of Trigeminal Afferents
NAActive, not recruiting
72 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04773834
Evaluation of an Automated Physician-Directed Messaging on Patient Engagement in the Digital Diabetes Prevention Program
NAActive, not recruiting
435 participants
Started: Feb 1, 2021 · Completed: Jun 1, 2025
1 condition2 sponsors1 location
NCT04727619
Evaluation of SLEEP Program
NAActive, not recruiting
210 participants
Started: Feb 1, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT04109638
Pulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery
NARecruiting
76 participants
Started: Feb 1, 2021 · Completed: Feb 28, 2026
3 conditions2 sponsors1 location
NCT06760845
Raman Spectroscopy Diagnosis of Kidney Diseases
N/ARecruiting
200 participants
Started: Feb 1, 2021 · Completed: Jul 31, 2025
4 conditions1 sponsor1 location
NCT05129696
"Integrating Early Stimulation and Play at Scale: MAHAY Mikolo"
PHASE3Recruiting
8,150 participants
Started: Feb 1, 2021 · Completed: Mar 31, 2025
1 condition4 sponsors1 location
NCT04578756
Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder
PHASE3Active, not recruiting
310 participants
Started: Feb 1, 2021 · Completed: Oct 31, 2025
3 conditions1 sponsor42 locations
NCT04606316
Surgical Nivolumab And Ipilimumab For Recurrent GBM
PHASE1Active, not recruiting
63 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2025
4 conditions2 sponsors4 locations
NCT03949478
Treating Postictal Symptoms Using Ibuprofen and Nifedipine
PHASE2Recruiting
90 participants
Started: Feb 1, 2021 · Completed: Mar 1, 2025
2 conditions1 sponsor2 locations
NCT04717570
Early Feasibility Study for the Foldax TRIA Mitral Heart Valve Replacement
NAActive, not recruiting
15 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor3 locations
NCT04455282
CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1
N/ARecruiting
100 participants
Started: Feb 1, 2021 · Completed: Jan 30, 2028
2 conditions2 sponsors2 locations